Vavricka John - Insider Non-Derivative Transactions at Atea Pharmaceuticals, Inc. (AVIR) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jan 31, 2025, Vavricka John's relationship to Atea Pharmaceuticals, Inc. (AVIR) is Officer (Chief Commercial Officer), and currently has 63,598 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other AVIR insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Vavricka John - Insider Non-Derivative Transactions of AVIR Common Stock

Vavricka John - Insider Non-Derivative Transactions at AVIR

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Feb 1, 2025	F -- (Common Stock)	11517	3.06	52081
Feb 1, 2025	M -- (Common Stock)	33333	0	54848
Feb 1, 2025	Acquisition -- (Common Stock)	8750	0	63598
Feb 2, 2024	Sell -- (Common Stock)	11819	3.84	21515
Feb 1, 2024	M -- (Common Stock)	33334	0	33334